Relationship between premature ventricular complexes and depressive symptoms in non-ST-elevation acute coronary syndrome by Whang, William et al.
 http://acc.sagepub.com/
Care
European Heart Journal: Acute Cardiovascular
 http://acc.sagepub.com/content/2/1/61
The online version of this article can be found at:
 
DOI: 10.1177/2048872613476101
 2013 2: 61 originally published online 29 January 2013European Heart Journal: Acute Cardiovascular Care
Karina W Davidson
William Whang, James Peacock, Ana V Soto, Tomas Borda, Anupama B Bhatt, Safiya I Richardson, Matthew Burg and
acute coronary syndrome





 European Society of Cardiology
 
 ESC Working Group on Acute Cardiac Care
and
 http://www.sagepublications.com





 http://acc.sagepub.com/cgi/alertsEmail Alerts: 
 





 What is This?
 
- Jan 29, 2013OnlineFirst Version of Record 
 
- Mar 7, 2013Version of Record >> 
 at COLUMBIA UNIV on March 22, 2013acc.sagepub.comDownloaded from 
European Heart Journal: Acute Cardiovascular Care
2(1) 61 –67
© The European Society of Cardiology 2013








Depression is a predictor of early mortality in patients after 
acute coronary syndrome (ACS), despite adjustment for 
coronary artery disease (CAD) severity.1,2 More than one-
third of all mortality in patients with CAD is due to sudden 
cardiac death, typically from arrhythmia such as sustained 
ventricular tachycardia or ventricular fibrillation,3 and 
studies in a variety of populations have suggested that 
depression is associated with sudden cardiac death and ven-
tricular arrhythmia.4–7 In a study of patients with implanta-
ble cardioverter defibrillators, depressive symptoms were 
associated with ventricular arrhythmias that resulted in 
shock for ventricular arrhythmia, and this relationship was 
stronger among the subgroup of patients with coronary 
artery disease.8
Cardiac monitoring has been used after ACS to detect 
arrhythmias, such as ventricular tachycardia or frequent pre-
mature ventricular complexes (PVCs). Even in the present 
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Abstract
Aims: Depression is a recognized risk marker for mortality among acute coronary syndrome (ACS) patients. We 
hypothesized that ventricular arrhythmia detected by inpatient telemetry monitoring is more frequent among ACS 
patients with elevated depressive symptoms compared to those without depressive symptoms.
Methods and results: We analysed data from patients enrolled in a prospective observational study of depression in 
ACS. Telemetry recordings during the index admission (average recording 21.3±3.0 hours) were analysed for frequent 
premature ventricular complexes (PVCs), defined as ≥10 per hour. The self-report Beck Depression Inventory (BDI) 
was used to assess depressive symptoms. Among 200 ACS patients, frequent PVCs were observed in 29% of patients 
with moderate depressive symptoms (BDI ≥10), 27% of those with mild symptoms (BDI 5–9), and only 11% of those with 
no/minimal symptoms (p=0.02). Log-transformed PVCs per hour were associated with depressive symptom category 
(p=0.008). In a multivariable logistic regression model that included age, gender, left ventricular ejection fraction, 
cardiovascular risk score, heart rate, and QT interval, mild symptoms (OR 3.02, 95% 0.97–9.43, p=0.058) and moderate-
severe symptoms (OR 3.94, 95% CI 1.27–12.22, p=0.018) were associated with frequent PVCs.
Conclusions: In this sample of ACS patients, depressive symptoms were independently associated with frequent PVCs 
during inpatient telemetry monitoring.
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era of coronary stenting and effective medical therapies, 
ventricular arrhythmia continues to be a risk marker for 
future mortality in ACS.9–12 There have been relatively few 
prior studies of the relationship between ventricular arrhyth-
mia and depression in CAD patients, with conflicting 
results.6,13,14 One of the initial studies that defined the impor-
tance of depression for prognosis after myocardial infarc-
tion documented a markedly elevated risk of mortality 
among patients with both depression and more ventricular 
arrhythmia in the form of frequent PVCs (odds ratio for 
interaction ~6).2
In this study we hypothesized that, among patients with 
ACS, depressive symptoms were associated with more fre-
quent ventricular arrhythmia in the form of PVCs measured 
by inpatient telemetry monitoring. In addition, based on a 
recent analysis that noted a gender difference in electrocar-
diographic QT interval changes associated with depressive 
symptoms,15 we hypothesized that there was a stronger 
relationship between PVCs and depressive symptoms in 
women than in men.
Methods
Institutional Review Board approval for this study was 
obtained at Columbia University. The cohort was drawn 
from among the first 500 patients enrolled in an ongoing 
prospective cohort study of depression after ACS, 
Prescription Use, Lifestyle, and Stress Evaluation (PULSE). 
Participants for this study were recruited from among 
patients admitted to Columbia University Medical Center 
between February 2009 and June 2010.
ACS events were defined according to American Heart 
Association/American College of Cardiology criteria16 as 
either acute myocardial infarction (MI) or unstable angina. 
All patients had symptoms consistent with acute myocardial 
ischaemia and at least one of the following: ischaemic elec-
trocardiographic changes (i.e. ST depression and/or T-wave 
abnormalities), an angiogram indicative of CAD on current 
admission, and/or documented history of CAD according to 
a stress test during the index admission or previous coronary 
angiogram. Patients who presented with an acute rise in 
serum troponin I levels >0.4 ng/ml were categorized as MI. 
A study cardiologist confirmed ACS eligibility for all 
patients. Patients with ST elevation were excluded from the 
analysis, to prevent possible confounding associated with 
reperfusion-related arrhythmias in this group.17,18
The Beck Depression Inventory (BDI),19 a 21-item self-
report measure of depressive symptom severity, was admin-
istered within 1 week after the index ACS event, while 
patients were still hospitalized, by research coordinators 
who were trained by study psychologists and whose inter-
views were reviewed regularly in order to standardize 
administration of assessment measures. The BDI has repeat-
edly been associated with long-term mortality after ACS.2,20–22 
Depressive symptoms were categorized according to BDI 
score: 0–4 (none/minimal symptoms), 5–9 (mild symp-
toms), or ≥10 (at least moderate symptoms).
Telemetry monitoring was performed via a 5-electrode 
continuous telemetry system that was fitted for clinical pur-
poses on patients during their hospital stay (Philips 
Healthcare). The telemetry system used a template match-
ing algorithm with a sampling rate of 125–250 samples per 
second to differentiate PVCs from normal QRS complexes 
in the ECG signal.23 The sensitivity of the algorithm for 
PVC detection based on an analysis of 44 non-paced test 
signals from the 2-channel MIT-Beth Israel Hospital ECG 
database was 94%, and the false positive rate was 0.3%.23 
Summary reports were generated that estimated PVC 
counts and median heart rate on an hourly basis (Figure 1) 
and samples of ECG tracings were collected with each 
summary report (Figure 2). These reports were obtained 
from the medical record and tracings with 12 or more hours 
of recordings were included in the analysis. A cardiac elec-
trophysiologist (WW) examined each tracing for accuracy 
blinded to BDI score, and tracings with false positive read-
ings for PVCs were removed. In addition, tracings with 
ventricular paced rhythms or with atrial fibrillation or atrial 
flutter were removed from the analysis to minimize false-
positive PVC counts. The simple average of PVC counts 
and heart rate during the recording period were estimated. 
PVC rates were dichotomized at ≥10 per hour or <10 per 
hour based on prior studies in patients with acute MI24,25 
and unstable angina.26
Twelve-lead ECG tracings from the index admission 
were obtained and the QT interval was measured from the 
onset of the QRS complex to the end of the T wave, defined 
as the point of return of the T wave to the isoelectric line or 
to the nadir between the T and U waves in cases where a U 
wave was present.27 QT intervals were corrected for heart 
rate according to Fridericia’s method (QTcF = QT/RR1/3).15
Statistical analysis
Linear-by-linear association chi-squared tests for trends 
and linear regression were used to compare categorical and 
continuous measurements between groups with no/minimal 
depressive symptoms, mild symptoms, and at least moder-
ate symptoms. Logistic regression models were used to 
estimate the relative odds of frequent PVCs (≥10 PVCs per 
hour) according to BDI category. Other variables included 
in the analyses were age, gender, non-white race, diabetes, 
left ejection fraction (LVEF), Global Registry of Acute 
Coronary Events (GRACE) risk score,28 pre-admission 
beta-blocker use, antidepressant use, anti-arrhythmic medi-
cation use, heart rate, QTcF, and percutaneous coronary 
intervention (PCI). Linear regression was performed with 
natural log transformation of (PVCs per hour + 1) and BDI 
category as a continuous variable (0 for BDI score 0–4, 1 
for BDI 5–9, or 2 for BDI ≥10). All analyses were per-
formed using SPSS version 18 (SPSS, Chicago, IL, USA).
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Figure 1. Example of cardiac telemetry report with median heart rate and premature ventricular complex counts per hour.
Figure 2. Sample of ECG tracing from cardiac telemetry report.
N, normal QRS complex detected by the automatic algorithm; V, premature ventricular complex.
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Results
Among the first 500 patients enrolled in PULSE, 443 
patients presented with non-ST-elevation ACS. Telemetry 
tracings were retrieved in 237 (54%) patients; the most 
common reason for lack of tracings was that summary 
telemetry reports became part of the medical record more 
than 5 months into the study, after 109 patients had already 
been enrolled in PULSE. Patients with and without retrieved 
tracings did not differ on the basis of age (p=0.10), sex 
(p=0.84), BDI score (p=0.64), or GRACE risk score 
(p=0.34). However, patients with retrieved tracings were 
less likely to have LVEF <0.40 (7.6% vs. 14.1%, p=0.03). 
Among those with retrieved tracings, 13 were removed 
from the analysis for misspecification of PVCs, eight for 
atrial fibrillation as the dominant rhythm, eight due to pre-
dominant ventricular pacing, five due to fewer than 12 
hours of recording, and three due to collection prior to PCI, 
resulting in a sample size of 200.
Among 200 ACS patients, 21.3±3.0 hours of telemetry 
tracings were collected per patient, and among the 152 
(76%) patients who underwent PCI during hospitalization, 
tracings were collected starting a median 5 hours after the 
intervention (interquartile range 3–12 hours). Minimal/no 
depressive symptoms were reported by 53 (27%) patients, 
68 (34%) had mild symptoms, and 79 (40%) had at least 
moderate symptoms (Table 1). Women and non-white 
patients were more likely to report depressive symptoms. 
The percentage of patients who presented with MI and who 
had reduced LVEF <0.40 did not differ significantly by 
BDI category. There was a U-shaped relationship between 
beta-blocker use and reported depressive symptoms, and as 
expected, antidepressant use was more common in the 
groups with higher BDI score. Average heart rate was simi-
lar across BDI category, and of note, QTcF was higher in 
patients with more than minimal/no depressive symptoms. 
Frequent PVCs were observed in only 11% of those with 
no/minimal symptoms, 27% of those with mild symptoms, 
and 29% of patients with moderate depressive symptoms 
(p for trend=0.02).
In a multivariable logistic regression model that included 
age, gender, non-white race, LVEF, GRACE risk score, dia-
betes, beta-blocker use, antidepressant use, anti-arrhythmic 
medication, heart rate, QTcF, and PCI (Table 2), there was 
a trend between mild symptoms (OR 3.02, 95% 0.97–9.43, 
p=0.058) and frequent PVCs, and a statistically significant 
relationship between moderate-severe symptoms (OR 3.94, 
95% CI 1.27–12.22, p=0.018) and frequent PVCs. Log-
transformed PVCs per hour were also associated with BDI 
category (1.11±1.25 for no/minimal symptoms, 1.61±1.47 
for mild symptoms, 1.81±1.57 for moderate symptoms, p 
for trend=0.008, Figure 3). In a multivariable linear regres-
sion that used the log-transformed PVC as the dependent 
variable, BDI category remained associated with more fre-
quent PVCs (Beta coefficient 0.36, 95% CI 0.09–0.63, 
p=0.009).
We did not detect a significant difference in the relation-
ship between PVCs and BDI category by gender. Although 
our numbers were relatively small, the multivariable odds 
ratios for frequent PVCs by BDI category were similar in 
men (odds ratio 3.04 for mild symptoms, 6.67 for moderate 
or more) and women (odds ratio 3.19 for mild symptoms, 
2.69 for moderate or more). Interaction terms for BDI cat-
egory and gender were not statistically significant in multi-
variable logistic regression models (p=0.30).
Discussion
In this analysis of patients with non-ST-elevation ACS, we 
found that depressive symptoms were associated with more 
frequent PVCs captured by inpatient cardiac telemetry 
Table 1. Demographic and clinical characteristics of ACS patients by depressive symptom status.
BDI 0–4 (n=53) BDI 5–9 (n=68) BDI ≥10 (n=79) p-value
Age (years) 62.3±11.9 65.4±10.5 64.1±10.5 0.50
Female 10 (18.9) 23 (33.8) 40 (50.6) <0.01
Non-white 15 (28.3) 28 (41.2) 37 (46.8) 0.04
Diabetes 23 (43.4) 19 (27.9) 34 (43.0) 0.84
Non-STEMI 18 (34.0) 24 (35.3) 20 (25.3) 0.25
LVEF <0.40 3 (5.7) 2 (2.9) 4 (5.1) 0.94
Antidepressant 0 (0) 3 (4.4) 6 (7.6) <0.01
Beta-blocker 39 (73.6) 44 (64.7) 69 (87.3) 0.04
Anti-arrhythmic 2 (3.8) 4 (5.9) 6 (7.6) 0.37
Heart rate (beats per minute) 67.6±9.6 68.5±10.9 67.4±9.4 0.99
QTcF 419.4±22.2 432.8±34.0 431.6±25.4 0.019
≥10 PVCs/h 6 (11.1) 18 (26.5) 23 (29.1) 0.02
Values are mean±standard deviation or n (%).
BDI, Beck Depression Inventory; LVEF, left ventricular ejection fraction; QTcF, QT corrected for heart rate using Fridericia’s method; STEMI, ST-
elevation myocardial infarction.
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monitoring. Moderate-severe depressive symptoms, repre-
sented by BDI score ≥10, were associated with frequent 
PVCs compared with no/minimal depressive symptoms. 
This relationship held despite adjustment for multiple 
potential confounders, including gender, left ventricular 
ejection fraction, cardiovascular risk score, and QT inter-
val. Thus, depressive symptoms may be associated with 
PVCs through mechanisms other than through QT interval 
prolongation. Our study adds to the current evidence base 
by reporting on an inpatient sample with ACS and by 
adjusting for more potential confounders than prior 
analyses.
There has been conflicting evidence as to whether ambi-
ent ventricular arrhythmia is more common in ACS patients 
with depression compared with those without depression. 
In a study of 103 patients with coronary artery disease, 
Carney documented more frequent ventricular arrhythmia 
by 24-hour ECG monitoring in 21 depressed patients 
(23.8%) compared with 82 non-depressed patients (3.7%), 
although patients with depression were also less likely to be 
treated with beta-blocker.13 By contrast, an analysis of 353 
post-MI patients from the Cardiac Arrhythmia Pilot Study 
indicated a lack of relationship between depressive symp-
toms and PVC rate by 24-hour ECG monitoring.14 However, 
an inclusion criterion for this study was at least 10 PVCs 
per hour by baseline ambulatory ECG monitoring, making 
this a highly selected sample. In the Very Anxious Group 
Under Scrutiny (VAGUS) study, among 940 patients 
referred for cardiac catheterization, during median follow 
up of 3 years both depressive symptoms by BDI score and 
phobic anxiety were associated with ventricular arrhythmia 
episodes captured from medical record review.29
Table 2. Multivariable logistic regression model of frequent 
premature ventricular complexes.
Odds ratio (95% CI) p-value
BDI 5–9 3.02 (0.97–9.43) 0.058
BDI ≥10 3.94 (1.27–12.22) 0.018
Age 1.01 (0.95–1.08) 0.67
Female 0.78 (0.34–1.79) 0.56
Non-white 1.69 (0.78–3.64) 0.18
Diabetes 1.09 (0.49–2.44) 0.84
GRACE score 1.02 (1.00–1.05) 0.06
LVEF (per 0.15 decrease) 2.16 (1.18–3.96) 0.01
Beta-blocker 0.93 (0.37–2.32) 0.87
Antidepressant 0.89 (0.16–4.97) 0.89
Anti-arrhythmic 0.62 (0.11–3.49) 0.59
Heart rate 1.00 (0.96–1.04) 0.95
QTcF 1.00 (0.99–1.01) 0.90
PCI 1.17 (0.43–2.89) 0.83
BDI, Beck Depression Inventory; GRACE, Global Registry of Acute 
Coronary Events; LVEF, left ventricular ejection fraction; PCI, percuta-
neous coronary intervention; QTcF, QT corrected for heart rate using 
Fridericia’s method.
Figure 3. Mean natural log-transformed premature ventricular complexes (PVC) per hour in 200 ACS patients by depressive 
symptom score.
Error bars indicate 95% confidence intervals. BDI, Beck Depression Inventory.
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In the study by Frasure-Smith and colleagues,2 among 
194 post-MI patients BDI score ≥10 was not related to fre-
quent PVC rates. However, 49% of the patients in this study 
underwent thrombolysis during the period of data collec-
tion from 1991 to 1992, implying that almost half the sam-
ple presented with ST-elevation MI (STEMI). In the present 
analysis we decided a priori not to include STEMI patients, 
but in order to better understand differences with the previ-
ous study we collected additional telemetry data from 33 
STEMI patients in PULSE. To our surprise, only one 
instance of frequent PVCs was noted (3%), a much lower 
prevalence than noted in the unstable angina and non-
STEMI patients in our sample. Thus, we would speculate 
that differences in the proportion of ACS patients with ST 
elevation explain the different relationship between BDI 
score and PVCs in the two studies.
There are several possible interpretations of our results. 
Depressive symptoms may be a marker for more severe car-
diac disease that is not detected by other measures such as 
cardiac risk score or LVEF. However, it is also plausible that 
depression itself has a causative role in more frequent ven-
tricular ectopy. Some,30–32 but not all,33,34 studies in coronary 
heart disease patients have suggested that depression is asso-
ciated with reduced parasympathetic modulation of heart 
rate as measured by heart rate variability. In a case–control 
study involving 40 patients with recent acute MI, Carney and 
colleagues showed that QT interval variability by 24-hour 
Holter monitoring, a predictor of arrhythmia risk, was sig-
nificantly greater in those with major depression.35 In addi-
tion, coronary sinus sampling has indicated that certain 
subtypes of depression are associated with elevated cardiac 
norepinephrine spillover.36 Given the recognized relation-
ships between autonomic nervous system activity and risk of 
cardiac arrhythmia and sudden cardiac death,37–39 depressive 
symptoms may trigger more frequent ventricular arrhythmia 
through mechanisms involving autonomic dysfunction.
Our analysis has several important limitations. Our 
study was from a single centre, was limited to patients with 
non-ST-elevation ACS, and had a relatively low proportion 
of patients with reduced LVEF, limiting its generalizability. 
The cardiac telemetry monitoring used for PVC detection 
was collected primarily for clinical purposes and despite 
close review of each ECG signal that was included with the 
summary reports, there may be misspecification of PVC 
counts. We would not however, expect the error rate to dif-
fer by BDI score and confound our findings on this basis. 
We also do not yet have data on cardiac event rates for this 
analysis and cannot evaluate how PVC counts interacted 
with the relationship between depressive symptoms in pre-
dicting cardiac mortality. Other physiological measures 
such as heart rate variability were also not available to us as 
we did not have full disclosure ECG data. Despite this, 
PVC rates are an easily obtainable clinical measure and 
may still serve as a useful indicator of cardiac risk in ACS 
patients with depressive symptoms. Also, the proportion of 
patients who were prescribed antidepressant medications 
was low, even among those with at least moderate symp-
toms, and we cannot assess how this therapy modulated the 
relationship between depressive symptoms and PVCs.
In summary, we found in this ACS sample that frequent 
PVCs detected by inpatient cardiac telemetry were associ-
ated with mild depressive symptoms. Further studies are 
warranted to assess the prognostic importance of ventricu-
lar arrhythmia in depressed patients and to define the mech-
anism of this relationship.
Funding
This work was supported by the National Institutes of Health 
(grants HL-088117, HC-25197, HL-076857, and HL-084034) and 
by a Scientist Development Grant to WW from the American Heart 
Association Founders Affiliate (grant number is 10SDG3720001).
References
 1. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic 
association of depression following myocardial infarction 
with mortality and cardiovascular events: a meta-analysis. 
Psychosom Med 2004; 66: 814–822.
 2. Frasure-Smith N, Lesperance F and Talajic M. Depression 
and 18-month prognosis after myocardial infarction. 
Circulation 1995; 91: 999–1005.
 3. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive 
summary: heart disease and stroke statistics – 2010 update: 
a report from the American Heart Association. Circulation 
2010; 121: 948–954.
 4. Empana JP, Jouven X, Lemaitre RN, et al. Clinical depres-
sion and risk of out-of-hospital cardiac arrest. Arch Intern 
Med 2006; 166: 195–200.
 5. Brackett CD and Powell LH. Psychosocial and physiologi-
cal predictors of sudden cardiac death after healing of acute 
myocardial infarction. Am J Cardiol 1988; 61: 979–983.
 6. Follick MJ, Gorkin L, Capone RJ, et al. Psychological 
distress as a predictor of ventricular arrhythmias in a post- 
myocardial infarction population. Am Heart J 1988; 116: 32–36.
 7. Lown B. Sudden cardiac death: biobehavioral perspective. 
Circulation 1987; 76: I186–I196.
 8. Whang W, Albert CM, Sears SF Jr, et al. Depression as a pre-
dictor for appropriate shocks among patients with implant-
able cardioverter-defibrillators: results from the Triggers of 
Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 
2005; 45: 1090–1095.
 9. Makikallio TH, Barthel P, Schneider R, et al. Prediction of 
sudden cardiac death after acute myocardial infarction: role 
of Holter monitoring in the modern treatment era. Eur Heart 
J 2005; 26: 762–769.
 10. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence 
and prognostic significance of ventricular arrhythmias after 
acute myocardial infarction in the fibrinolytic era. GISSI-2 
results. Circulation 1993; 87: 312–322.
 11. Hohnloser SH, Klingenheben T, Zabel M, et al. Prevalence, 
characteristics and prognostic value during long-term follow-
up of nonsustained ventricular tachycardia after myocardial 
infarction in the thrombolytic era. J Am Coll Cardiol 1999; 
33: 1895–1902.
 at COLUMBIA UNIV on March 22, 2013acc.sagepub.comDownloaded from 
Whang et al. 67
 12. Drogemuller A, Seidl K, Schiele R, et al. Prognostic value of 
non-sustained ventricular tachycardias after acute myocar-
dial infarction in the thrombolytic era: importance of combi-
nation with frequent ventricular premature beats. Z Kardiol 
2003; 92: 164–172.
 13. Carney RM, Freedland KE, Rich MW, et al. Ventricular tach-
ycardia and psychiatric depression in patients with coronary 
artery disease. Am J Med 1993; 95: 23–28.
 14. Follick MJ, Ahern DK, Gorkin L, et al. Relation of psychoso-
cial and stress reactivity variables to ventricular arrhythmias 
in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 
1990; 66: 63–67.
 15. Whang W, Julien HM, Higginbotham L, et al. Women, but 
not men, have prolonged QT interval if depressed after an 
acute coronary syndrome. Europace 2012; 14: 267–271.
 16. Cannon CP, Battler A, Brindis RG, et al. American College 
of Cardiology key data elements and definitions for meas-
uring the clinical management and outcomes of patients 
with acute coronary syndromes. A report of the American 
College of Cardiology Task Force on Clinical Data Standards 
(Acute Coronary Syndromes Writing Committee). J Am Coll 
Cardiol 2001; 38: 2114–2130.
 17. Majidi M, Kosinski AS, Al-Khatib SM, et al. Reperfusion 
ventricular arrhythmia ‘bursts’ in TIMI 3 flow restoration 
with primary angioplasty for anterior ST-elevation myo-
cardial infarction: a more precise definition of reperfusion 
arrhythmias. Europace 2008; 10: 988–997.
 18. Cercek B, Lew AS, Laramee P, et al. Time course and charac-
teristics of ventricular arrhythmias after reperfusion in acute 
myocardial infarction. Am J Cardiol 1987; 60: 214–218.
 19. Beck AT, Ward CH, Mendelson M, et al. An inventory for 
measuring depression. Arch Gen Psychiatryy 1961; 4: 
561–571.
 20. Lesperance F, Frasure-Smith N, Juneau M, et al. Depression 
and 1-year prognosis in unstable angina. Arch Intern Med 
2000; 160: 1354–1360.
 21. Whang W, Shimbo D, Kronish IM, et al. Depressive symp-
toms and all-cause mortality in unstable angina pectoris 
(from the Coronary Psychosocial Evaluation Studies COPES). 
Am J Cardiol 2010; 106: 1104–1107.
 22. Rutledge T, Reis SE, Olson M, et al. Depression is associated 
with cardiac symptoms, mortality risk, and hospitalization 
among women with suspected coronary disease: the NHLBI-
sponsored WISE study. Psychosom Med 2006; 68: 217–223.
 23. Wang J, Yeo CL and Aguirre A. The design and evalua-
tion of a new multi-lead arrhythmia monitoring algorithm. 
Computers in Cardiology 1999; 26: 675–678.
 24. Kleiger RE, Miller JP, Bigger JT Jr, et al. Decreased heart 
rate variability and its association with increased mortality 
after acute myocardial infarction. Am J Cardiol 1987; 59: 
256–262.
 25. Risk stratification and survival after myocardial infarction. N 
Engl J Med 1983; 309: 331–336.
 26. Lanza GA, Cianflone D, Rebuzzi AG, et al. Prognostic 
value of ventricular arrhythmias and heart rate variability in 
patients with unstable angina. Heart 2006; 92: 1055–1063.
 27. Lepeschkin E and Surawicz B. The measurement of the 
Q-T interval of the electrocardiogram. Circulation 1952; 6: 
378–388.
 28. Eagle KA, Lim MJ, Dabbous OH, et al. A validated pre-
diction model for all forms of acute coronary syndrome: 
estimating the risk of 6-month postdischarge death in an 
international registry. JAMA 2004; 291: 2727–2733.
 29. Watkins LL, Blumenthal JA, Davidson JR, et al. Phobic 
anxiety, depression, and risk of ventricular arrhythmias in 
patients with coronary heart disease. Psychosom Med 2006; 
68: 651–656.
 30. Carney RM, Blumenthal JA, Stein PK, et al. Depression, 
heart rate variability, and acute myocardial infarction. 
Circulation 2001; 104: 2024–2028.
 31. Stein PK, Carney RM, Freedland KE, et al. Severe depression 
is associated with markedly reduced heart rate variability in 
patients with stable coronary heart disease. J Psychosom Res 
2000; 48: 493–500.
 32. Carney RM, Blumenthal JA, Freedland KE, et al. Low 
heart rate variability and the effect of depression on post-
myocardial infarction mortality. Arch Intern Med 2005; 165: 
1486–1491.
 33. Gehi A, Mangano D, Pipkin S, et al. Depression and heart 
rate variability in patients with stable coronary heart disease: 
findings from the Heart and Soul Study. Arch Gen Psychiatry 
2005; 62: 661–666.
 34. Frasure-Smith N, Lesperance F, Irwin MR, et al. The rela-
tionships among heart rate variability, inflammatory mark-
ers and depression in coronary heart disease patients. Brain 
Behav Immun 2009; 23: 1140–1147.
 35. Carney RM, Freedland KE, Stein PK, et al. Effects of depres-
sion on QT interval variability after myocardial infarction. 
Psychosom Med 2003; 65: 177–180.
 36. Barton DA, Dawood T, Lambert EA, et al. Sympathetic 
activity in major depressive disorder: identifying those at 
increased cardiac risk? J Hypertens 2007; 25: 2117–2124.
 37. Zipes DP, Levy MN, Cobb LA, et al. Sudden cardiac 
death. Neural-cardiac interactions. Circulation 1987; 76: 
I202–I207.
 38. Schwartz PJ, La Rovere MT and Vanoli E. Autonomic nerv-
ous system and sudden cardiac death. Experimental basis 
and clinical observations for post-myocardial infarction risk 
stratification. Circulation 1992; 85: I77–I91.
 39. Chen LS, Zhou S, Fishbein MC, et al. New perspectives 
on the role of autonomic nervous system in the genesis of 
arrhythmias. J Cardiovasc Electrophysiol 2007; 18: 123–127.
 at COLUMBIA UNIV on March 22, 2013acc.sagepub.comDownloaded from 
